Reports Summarize Heart Attack Study Results from Dartmouth College (Incorporating Behavioral Science In Medication Adherence Communication: a Randomized Clinical Trial): Heart Disorders and Diseases – Heart Attack

2025 JUN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Fresh data on Heart Disorders and Diseases - Heart Attack are presented in a new report. According to news originating from Hanover, New Hampshire, by NewsRx correspondents, research stated, “Importance Hypertension increases the risk of myocardial infarction and strokes, but adherence to antihypertensive medications remains suboptimal. Increasing medication adherence may help prevent hypertension-related disability and death.”

Financial support for this research came from NIH National Institute on Aging (NIA).

Our news journalists obtained a quote from the research from Dartmouth College, “To estimate the effect of incorporating behavioral science principles in mailed communications intended to increase hypertension medication adherence. Setting, and Participants This randomized clinical trial was conducted from August 18 to December 31, 2023, at Humana, a large health insurance provider, and included Medicare Advantage beneficiaries aged 65 to 80 years who were taking hypertension medications with adherence rates of 60% to 85%. Data were extracted for the as-treated analysis on April 14, 2024. Study participants were randomized in equal proportions to 1 of 7 groups: 6 received mailed communications that incorporated combinations of behavioral science principles, and 1 received no mailing (control, or usual care condition). The specific principles included were social norming (the mailing noted that more Humana beneficiaries each year were improving their medication adherence scores), messenger effects (the mailing signatory was a pharmacist), and processing fluency (the mailing incorporated a visual circle metaphor indicating current and complete adherence to prompt ‘closing the ring’). The first mailing contained the participant’s baseline refill score, and a second mailing noted any changes in the participant’s refill score after 60 days. Main Outcomes and Measures The primary outcome was end-of-year hypertension medication adherence calculated from pharmacy claims data using the proportion of days covered (PDC) metric (having medication available for 1 target hypertension drug, as measured through prescription claims, counted as adherent on a given day). A secondary outcome was the proportion of study participants with end-of-year PDC of 80% or greater. The study participants (n = 64 290) had a mean (SD) age of 71.4 (4.1) years, and 54.1% were female. Mean (SD) end-of-year adherence in the control group was 0.81 (0.12) and was no different in any of the intervention arms (absolute mean difference compared with control was 0.00 [95% CI, -0.01 to 0.01]). The proportion of participants with an end-of-year PDC greater than 80% also did not differ significantly between the control group (6587 of 9183 [71.7%]) and any of the intervention arms (range, 6467 of 9180 [70.4%] to 6598 of 9177 [71.9%]). Conclusions and Relevance In this randomized clinical trial, use of social norms, messenger effects, and processing fluency in mailed communications did not significantly increase hypertension medication adherence. Further research is needed to identify tactics to effectively increase adherence.”

According to the news editors, the research concluded: “Trial Registration ClinicalTrials.gov Identifier: NCT06066541.”

For more information on this research see: Incorporating Behavioral Science In Medication Adherence Communication: a Randomized Clinical Trial. JAMA Network Open, 2025;8(5). JAMA Network Open can be contacted at: Amer Medical Assoc, 330 N Wabash Ave, Ste 39300, Chicago, IL 60611-5885, USA.

The news correspondents report that additional information may be obtained from Punam Keller, Dartmouth College, Tuck School of Business, 100 Tuck Hall, Hanover, NH 03755, United States. Additional authors for this research include Ted Robertson, Lee-Sien Kao, Yong Li, Brandon Merrell, Linda Chung, Emily Boudreau, Alex James, Lauren Esterly, Kaitlin Hanken and Niteesh K. Choudhry.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1001/jamanetworkopen.2025.10162. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)